Abstract
The receptor-interacting serine/threonine-protein kinase-2 (RIPK2, RIP2) is a key player in downstream signaling of nuclear oligomerization domain (NOD)-like receptor (NLR)-mediated innate immune response against bacterial infections. RIPK2 is recruited following activation of the pattern recognition receptors (PRRs) NOD1 and NOD2 by sensing bacterial peptidoglycans leading to activation of NF-κB and MAPK pathways and the production of pro-inflammatory cytokines. Upon NOD1/2 activation, RIPK2 forms complexes in the cytoplasm of human cells, also called RIPosomes. These can be induced by Shigella flexneri or by the inhibition of RIPK2 by small compounds, such as GSK583 and gefitinib.
In this chapter, we describe fluorescent light microscopic and Western blot approaches to analyze the cytoplasmic aggregation of RIPK2 upon infection with the invasive, Gram-negative bacterial pathogen Shigella flexneri, or by the treatment with RIPK2 inhibitors. This method is based on HeLa cells stably expressing eGFP-tagged RIPK2 and describes a protocol to induce and visualize RIPosome formation. The described method is useful to study the deposition of RIPK2 in speck-like structures, also in living cells, using live cell imaging and can be adopted for the study of other inhibitory proteins or to further analyze the process of RIPosome structure assembly.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Girardin SE, Tournebize R, Mavris M, Page AL, Li X, Stark GR, Bertin J, DiStefano PS, Yaniv M, Sansonetti PJ, Philpott DJ (2001) CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep 2(8):736–742. https://doi.org/10.1093/embo-reports/kve155
Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276(7):4812–4818. https://doi.org/10.1074/jbc.M008072200
Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE (2014) NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol 14(1):9–23. https://doi.org/10.1038/nri3565
Topal Y, Gyrd-Hansen M (2020) RIPK2 NODs to XIAP and IBD. Semin Cell Dev Biol. https://doi.org/10.1016/j.semcdb.2020.07.001
Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, Ferguson DJP, Campbell BJ, Jewell D, Simmons A (2010) NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 16(1):90–97. https://doi.org/10.1038/nm.2069
Pellegrini E, Desfosses A, Wallmann A, Schulze WM, Rehbein K, Mas P, Signor L, Gaudon S, Zenkeviciute G, Hons M, Malet H, Gutsche I, Sachse C, Schoehn G, Oschkinat H, Cusack S (2018) RIP2 filament formation is required for NOD2 dependent NF-kappaB signalling. Nat Commun 9(1):4043. https://doi.org/10.1038/s41467-018-06451-3
Gong Q, Long Z, Zhong FL, Teo DET, Jin Y, Yin Z, Boo ZZ, Zhang Y, Zhang J, Yang R, Bhushan S, Reversade B, Li Z, Wu B (2018) Structural basis of RIP2 activation and signaling. Nat Commun 9(1):4993. https://doi.org/10.1038/s41467-018-07447-9
Ellwanger K, Briese S, Arnold C, Kienes I, Heim V, Nachbur U, Kufer TA (2019) XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures. Life Sci Alliance 2(4). https://doi.org/10.26508/lsa.201900346
Pellegrini E, Signor L, Singh S, Boeri Erba E, Cusack S (2017) Structures of the inactive and active states of RIP2 kinase inform on the mechanism of activation. PLoS One 12(5):e0177161. https://doi.org/10.1371/journal.pone.0177161
Tigno-Aranjuez JT, Asara JM, Abbott DW (2010) Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses. Genes Dev 24(23):2666–2677. https://doi.org/10.1101/gad.1964410
Krieg A, Correa RG, Garrison JB, Le Negrate G, Welsh K, Huang Z, Knoefel WT, Reed JC (2009) XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci U S A 106(34):14524–14529. https://doi.org/10.1073/pnas.0907131106
Goncharov T, Hedayati S, Mulvihill MM, Izrael-Tomasevic A, Zobel K, Jeet S, Fedorova AV, Eidenschenk C, deVoss J, Yu K, Shaw AS, Kirkpatrick DS, Fairbrother WJ, Deshayes K, Vucic D (2018) Disruption of XIAP-RIP2 association blocks NOD2-mediated inflammatory signaling. Mol Cell 69(4):551–565 e557. https://doi.org/10.1016/j.molcel.2018.01.016
Nachbur U, Stafford CA, Bankovacki A, Zhan Y, Lindqvist LM, Fiil BK, Khakham Y, Ko HJ, Sandow JJ, Falk H, Holien JK, Chau D, Hildebrand J, Vince JE, Sharp PP, Webb AI, Jackman KA, Muhlen S, Kennedy CL, Lowes KN, Murphy JM, Gyrd-Hansen M, Parker MW, Hartland EL, Lew AM, Huang DC, Lessene G, Silke J (2015) A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production. Nat Commun 6:6442. https://doi.org/10.1038/ncomms7442
Haile PA, Votta BJ, Marquis RW, Bury MJ, Mehlmann JF, Singhaus R Jr, Charnley AK, Lakdawala AS, Convery MA, Lipshutz DB, Desai BM, Swift B, Capriotti CA, Berger SB, Mahajan MK, Reilly MA, Rivera EJ, Sun HH, Nagilla R, Beal AM, Finger JN, Cook MN, King BW, Ouellette MT, Totoritis RD, Pierdomenico M, Negroni A, Stronati L, Cucchiara S, Ziolkowski B, Vossenkamper A, MacDonald TT, Gough PJ, Bertin J, Casillas LN (2016) The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a highly potent and selective inhibitor of RIP2 kinase. J Med Chem 59(10):4867–4880. https://doi.org/10.1021/acs.jmedchem.6b00211
Steinle H, Ellwanger K, Mirza N, Briese S, Kienes I, Pfannstiel J, Kufer TA (2021) 14-3-3 and erlin proteins differentially interact with RIPK2 complexes. J Cell Sci 134(12). https://doi.org/10.1242/jcs.258137
Moretti J, Blander JM (2017) Cell-autonomous stress responses in innate immunity. J Leukoc Biol 101(1):77–86. https://doi.org/10.1189/jlb.2MR0416-201R
Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F, Nuñez G, Fernandez-Luna JL (2002) Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation. J Biol Chem 277(44):41701–41705. https://doi.org/10.1074/jbc.M206473200
Clerc P, Sansonetti PJ (1987) Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation. Infect Immun 55(11):2681–2688
Meitert T, Pencu E, Ciudin L, Tonciu M, Mihai I, Nicolescu S (1991) Correlation between Congo red binding as virulence marker in Shigella species and Sereny test. Roum Arch Microbiol Immunol 50(1):45–52
Maurelli AT (1989) Temperature regulation of virulence genes in pathogenic bacteria: a general strategy for human pathogens? Microb Pathog 7(1):1–10. https://doi.org/10.1016/0882-4010(89)90106-x
Kufer TA, Kremmer E, Adam AC, Philpott DJ, Sansonetti PJ (2008) The pattern-recognition molecule Nod1 is localized at the plasma membrane at sites of bacterial interaction. Cell Microbiol 10(2):477–486. https://doi.org/10.1111/j.1462-5822.2007.01062.x
Valencia-Gallardo CM, Carayol N, Tran Van Nhieu G (2015) Cytoskeletal mechanics during Shigella invasion and dissemination in epithelial cells. Cell Microbiol 17(2):174–182. https://doi.org/10.1111/cmi.12400
Stephens DJ, Allan VJ (2003) Light microscopy techniques for live cell imaging. Science 300(5616):82–86. https://doi.org/10.1126/science.1082160
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Steinle, H., Ellwanger, K., Kufer, T.A. (2022). Assaying RIPK2 Activation by Complex Formation. In: Kufer, T.A., Kaparakis-Liaskos, M. (eds) Effector-Triggered Immunity. Methods in Molecular Biology, vol 2523. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2449-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2449-4_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2448-7
Online ISBN: 978-1-0716-2449-4
eBook Packages: Springer Protocols